Related Experiment Videos
Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment
Insights
Cefaclor suspension effectively treated bacterial infections in children, including acute otitis media. This antibiotic showed good patient acceptance and rapid symptom relief, with no observed side effects.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology
- Bacteriology
Background:
- Acute otitis media and respiratory tract infections are common in infants and children.
- Bacterial pathogens, including ampicillin-resistant strains, are often implicated.
- Effective and well-tolerated antibiotic options are needed for pediatric infections.
Purpose of the Study:
- To evaluate the efficacy and tolerability of cefaclor suspension in treating bacterial infections in pediatric patients.
- To assess the drug's activity against common pathogens causing acute otitis media and respiratory infections.
Main Methods:
- Oral administration of cefaclor suspension to 22 infants and children.
- Treatment of acute otitis media and/or other infections, primarily of the respiratory tract.
- Clinical observation for symptom resolution and side effects.
Main Results:
- Cefaclor was easily accepted by pediatric patients.
- No adverse side effects were reported during the study.
- Most patients experienced symptom resolution within 48 hours.
- Cefaclor demonstrated activity against key pathogens, including ampicillin-resistant Hemophilus influenzae.
Conclusions:
- Cefaclor appears to be an effective bactericidal agent for upper respiratory tract infections in children.
- The drug is well-tolerated and shows promise for treating acute otitis media.
- Caution is advised in bacteremic infants due to potential for poor cerebrospinal fluid penetration and meningitis risk.
Abstract:
Cefaclor, a new semisynthetic cephalosporin, was given orally as a suspension to 22 infants and children with acute otitis media and or/other infections, mainly of the respiratory tract, suspected to be of bacterial origin. The drug was found to be very easily accepted by the patients, and no side effects were encountered. Most patients became asymptomatic within 48 hours. Cefaclor is active against most bacteria producing acute otitis media, including ampicillin-resistant Hemophilus influenzae, and seems to be an effective bactericidal agent in the treatment of upper respiratory tract infections. Caution is recommended when used in bacteremic infants who do not respond promptly to therapy, in view of the poor cerebrospinal fluid levels of the drug and the danger of meningitis.